{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"Serum samples will be collected for the analysis of the presence of ADAs using validated immunoassays. All samples will be tested in screening assay, and positive samples will be further characterized for antibody titers.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 255 weeks","title":"Number of Participants With Positive Anti-Drug Antibodies (ADAs) Against Belantamab Mafodotin","type":"SECONDARY"}